Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Erik Zimmerman
Introduction
Erik Zimmerman is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies and amino acid synthetases. With a total of 5 patents to his name, Zimmerman's work is paving the way for advancements in medical treatments and diagnostics.
Latest Patents
Zimmerman's latest patents include groundbreaking inventions such as "Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use." This patent details antibodies that incorporate multiple non-natural amino acid residues at specific positions, along with methods for their production and application. These antibodies are particularly useful for treatment, prevention, detection, and diagnosis in various medical contexts. Another significant patent is "Non-natural amino acid tRNA synthetases for pyridyl tetrazine," which provides methods and compositions for a mutein aminoacyl-tRNA synthetase that preferentially charges a tRNA with a non-natural amino acid. This invention facilitates the incorporation of pyridinyl-amino tetrazine amino acids into proteins, allowing for the conjugation of biologically active adducts.
Career Highlights
Erik Zimmerman is currently associated with Sutro Biopharma, Inc., where he continues to innovate in the biopharmaceutical sector. His work focuses on enhancing the efficacy of therapeutic antibodies and developing novel methods for protein synthesis.
Collaborations
Zimmerman collaborates with esteemed colleagues such as Christopher D. Thanos and Ramesh Baliga, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Erik Zimmerman's contributions to the field of biopharmaceuticals through his patents and collaborative efforts highlight his role as a leading inventor. His work is instrumental in advancing medical science and improving treatment methodologies.